Aegerion Pharmaceuticals

Global Hunter initiated its coverage of Aegerion Pharmaceuticals (NASDAQ: AEGR) with a Buy rating and a price target of $23. On Monday, Aegerion lost 0.78% of its value to finish the day at $15.29.